Global Preimplantation Genetic Diagnosis (PGD) Market Research Report 2023

Global Preimplantation Genetic Diagnosis (PGD) Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chromosomal Abnormalities
1.2.3 Gender Selection
1.2.4 X-linked Diseases
1.2.5 Aneuploidy
1.2.6 Single Gene Disorders
1.2.7 Others
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Diagnosis (PGD) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals, Diagnostic Labs, and Service Providers
1.3.4 Research Laboratories & Academic Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Perspective (2018-2029)
2.2 Preimplantation Genetic Diagnosis (PGD) Growth Trends by Region
2.2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Region (2018-2023)
2.2.3 Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2024-2029)
2.3 Preimplantation Genetic Diagnosis (PGD) Market Dynamics
2.3.1 Preimplantation Genetic Diagnosis (PGD) Industry Trends
2.3.2 Preimplantation Genetic Diagnosis (PGD) Market Drivers
2.3.3 Preimplantation Genetic Diagnosis (PGD) Market Challenges
2.3.4 Preimplantation Genetic Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetic Diagnosis (PGD) Players by Revenue (2018-2023)
3.1.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2018-2023)
3.2 Global Preimplantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetic Diagnosis (PGD) Revenue
3.4 Global Preimplantation Genetic Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnosis (PGD) Revenue in 2022
3.5 Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetic Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetic Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetic Diagnosis (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Type (2018-2023)
4.2 Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2024-2029)
5 Preimplantation Genetic Diagnosis (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Application (2018-2023)
5.2 Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Preimplantation Genetic Diagnosis (PGD) Market Size (2018-2029)
6.2 North America Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023)
6.4 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preimplantation Genetic Diagnosis (PGD) Market Size (2018-2029)
7.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023)
7.4 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size (2018-2029)
8.2 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2018-2023)
8.4 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size (2018-2029)
9.2 Latin America Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023)
9.4 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size (2018-2029)
10.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023)
10.4 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Introduction
11.1.4 Illumina Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Detail
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Introduction
11.2.4 Thermo Fisher Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.2.5 Thermo Fisher Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Introduction
11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.3.5 Agilent Technologies Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Detail
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Introduction
11.4.4 PerkinElmer Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.4.5 PerkinElmer Recent Development
11.5 Coopersurgical
11.5.1 Coopersurgical Company Detail
11.5.2 Coopersurgical Business Overview
11.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Introduction
11.5.4 Coopersurgical Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.5.5 Coopersurgical Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Introduction
11.6.4 Abbott Laboratories Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 Natera
11.7.1 Natera Company Detail
11.7.2 Natera Business Overview
11.7.3 Natera Preimplantation Genetic Diagnosis (PGD) Introduction
11.7.4 Natera Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.7.5 Natera Recent Development
11.8 Takara Bio
11.8.1 Takara Bio Company Detail
11.8.2 Takara Bio Business Overview
11.8.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Introduction
11.8.4 Takara Bio Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.8.5 Takara Bio Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Detail
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Introduction
11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.9.5 Oxford Gene Technology Recent Development
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Detail
11.10.2 Yikon Genomics Business Overview
11.10.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Introduction
11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.10.5 Yikon Genomics Recent Development
11.11 Progenesis
11.11.1 Progenesis Company Detail
11.11.2 Progenesis Business Overview
11.11.3 Progenesis Preimplantation Genetic Diagnosis (PGD) Introduction
11.11.4 Progenesis Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.11.5 Progenesis Recent Development
11.12 Beijing Genomics Institute
11.12.1 Beijing Genomics Institute Company Detail
11.12.2 Beijing Genomics Institute Business Overview
11.12.3 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Introduction
11.12.4 Beijing Genomics Institute Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.12.5 Beijing Genomics Institute Recent Development
11.13 Invitae
11.13.1 Invitae Company Detail
11.13.2 Invitae Business Overview
11.13.3 Invitae Preimplantation Genetic Diagnosis (PGD) Introduction
11.13.4 Invitae Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.13.5 Invitae Recent Development
11.14 Invicta Genetics
11.14.1 Invicta Genetics Company Detail
11.14.2 Invicta Genetics Business Overview
11.14.3 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Introduction
11.14.4 Invicta Genetics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.14.5 Invicta Genetics Recent Development
11.15 Combimatrix
11.15.1 Combimatrix Company Detail
11.15.2 Combimatrix Business Overview
11.15.3 Combimatrix Preimplantation Genetic Diagnosis (PGD) Introduction
11.15.4 Combimatrix Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.15.5 Combimatrix Recent Development
11.16 Genea Limited
11.16.1 Genea Limited Company Detail
11.16.2 Genea Limited Business Overview
11.16.3 Genea Limited Preimplantation Genetic Diagnosis (PGD) Introduction
11.16.4 Genea Limited Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.16.5 Genea Limited Recent Development
11.17 Bioarray
11.17.1 Bioarray Company Detail
11.17.2 Bioarray Business Overview
11.17.3 Bioarray Preimplantation Genetic Diagnosis (PGD) Introduction
11.17.4 Bioarray Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.17.5 Bioarray Recent Development
11.18 Quest Diagnostics
11.18.1 Quest Diagnostics Company Detail
11.18.2 Quest Diagnostics Business Overview
11.18.3 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Introduction
11.18.4 Quest Diagnostics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
11.18.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Chromosomal Abnormalities
Table 3. Key Players of Gender Selection
Table 4. Key Players of X-linked Diseases
Table 5. Key Players of Aneuploidy
Table 6. Key Players of Single Gene Disorders
Table 7. Key Players of Others
Table 8. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Region (2018-2023)
Table 12. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Region (2024-2029)
Table 14. Preimplantation Genetic Diagnosis (PGD) Market Trends
Table 15. Preimplantation Genetic Diagnosis (PGD) Market Drivers
Table 16. Preimplantation Genetic Diagnosis (PGD) Market Challenges
Table 17. Preimplantation Genetic Diagnosis (PGD) Market Restraints
Table 18. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Players (2018-2023)
Table 20. Global Top Preimplantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis (PGD) as of 2022)
Table 21. Ranking of Global Top Preimplantation Genetic Diagnosis (PGD) Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Preimplantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Preimplantation Genetic Diagnosis (PGD) Product Solution and Service
Table 25. Date of Enter into Preimplantation Genetic Diagnosis (PGD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2018-2023)
Table 29. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2024-2029)
Table 31. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2018-2023)
Table 33. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2024-2029)
Table 35. North America Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029) & (US$ Million)
Table 50. Illumina Company Detail
Table 51. Illumina Business Overview
Table 52. Illumina Preimplantation Genetic Diagnosis (PGD) Product
Table 53. Illumina Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 54. Illumina Recent Development
Table 55. Thermo Fisher Company Detail
Table 56. Thermo Fisher Business Overview
Table 57. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product
Table 58. Thermo Fisher Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 59. Thermo Fisher Recent Development
Table 60. Agilent Technologies Company Detail
Table 61. Agilent Technologies Business Overview
Table 62. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product
Table 63. Agilent Technologies Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 64. Agilent Technologies Recent Development
Table 65. PerkinElmer Company Detail
Table 66. PerkinElmer Business Overview
Table 67. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product
Table 68. PerkinElmer Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 69. PerkinElmer Recent Development
Table 70. Coopersurgical Company Detail
Table 71. Coopersurgical Business Overview
Table 72. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product
Table 73. Coopersurgical Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 74. Coopersurgical Recent Development
Table 75. Abbott Laboratories Company Detail
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product
Table 78. Abbott Laboratories Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 79. Abbott Laboratories Recent Development
Table 80. Natera Company Detail
Table 81. Natera Business Overview
Table 82. Natera Preimplantation Genetic Diagnosis (PGD) Product
Table 83. Natera Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 84. Natera Recent Development
Table 85. Takara Bio Company Detail
Table 86. Takara Bio Business Overview
Table 87. Takara Bio Preimplantation Genetic Diagnosis (PGD) Product
Table 88. Takara Bio Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 89. Takara Bio Recent Development
Table 90. Oxford Gene Technology Company Detail
Table 91. Oxford Gene Technology Business Overview
Table 92. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product
Table 93. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 94. Oxford Gene Technology Recent Development
Table 95. Yikon Genomics Company Detail
Table 96. Yikon Genomics Business Overview
Table 97. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product
Table 98. Yikon Genomics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 99. Yikon Genomics Recent Development
Table 100. Progenesis Company Detail
Table 101. Progenesis Business Overview
Table 102. Progenesis Preimplantation Genetic Diagnosis (PGD) Product
Table 103. Progenesis Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 104. Progenesis Recent Development
Table 105. Beijing Genomics Institute Company Detail
Table 106. Beijing Genomics Institute Business Overview
Table 107. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product
Table 108. Beijing Genomics Institute Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 109. Beijing Genomics Institute Recent Development
Table 110. Invitae Company Detail
Table 111. Invitae Business Overview
Table 112. Invitae Preimplantation Genetic Diagnosis (PGD) Product
Table 113. Invitae Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 114. Invitae Recent Development
Table 115. Invicta Genetics Company Detail
Table 116. Invicta Genetics Business Overview
Table 117. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product
Table 118. Invicta Genetics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 119. Invicta Genetics Recent Development
Table 120. Combimatrix Company Detail
Table 121. Combimatrix Business Overview
Table 122. Combimatrix Preimplantation Genetic Diagnosis (PGD) Product
Table 123. Combimatrix Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 124. Combimatrix Recent Development
Table 125. Genea Limited Company Detail
Table 126. Genea Limited Business Overview
Table 127. Genea Limited Preimplantation Genetic Diagnosis (PGD) Product
Table 128. Genea Limited Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 129. Genea Limited Recent Development
Table 130. Bioarray Company Detail
Table 131. Bioarray Business Overview
Table 132. Bioarray Preimplantation Genetic Diagnosis (PGD) Product
Table 133. Bioarray Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 134. Bioarray Recent Development
Table 135. Quest Diagnostics Company Detail
Table 136. Quest Diagnostics Business Overview
Table 137. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product
Table 138. Quest Diagnostics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
Table 139. Quest Diagnostics Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetic Diagnosis (PGD) Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Type: 2022 VS 2029
Figure 3. Chromosomal Abnormalities Features
Figure 4. Gender Selection Features
Figure 5. X-linked Diseases Features
Figure 6. Aneuploidy Features
Figure 7. Single Gene Disorders Features
Figure 8. Others Features
Figure 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Application: 2022 VS 2029
Figure 11. Maternity Centers & Fertility Clinics Case Studies
Figure 12. Hospitals, Diagnostic Labs, and Service Providers Case Studies
Figure 13. Research Laboratories & Academic Institutes Case Studies
Figure 14. Preimplantation Genetic Diagnosis (PGD) Report Years Considered
Figure 15. Global Preimplantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Preimplantation Genetic Diagnosis (PGD) Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Region: 2022 VS 2029
Figure 18. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Players in 2022
Figure 19. Global Top Preimplantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis (PGD) as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnosis (PGD) Revenue in 2022
Figure 21. North America Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2018-2029)
Figure 23. United States Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2018-2029)
Figure 27. Germany Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Share by Region (2018-2029)
Figure 35. China Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2018-2029)
Figure 43. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2018-2029)
Figure 47. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Illumina Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 50. Thermo Fisher Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 51. Agilent Technologies Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 52. PerkinElmer Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 53. Coopersurgical Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 54. Abbott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 55. Natera Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 56. Takara Bio Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 57. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 58. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 59. Progenesis Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 60. Beijing Genomics Institute Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 61. Invitae Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 62. Invicta Genetics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 63. Combimatrix Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 64. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 65. Bioarray Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 66. Quest Diagnostics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs